It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2008.
2008 | Mumbai, Maharashtra, India | ActiveRuby Biopharma Private Limited, a active private limited company, was established on 21 January 2008 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24234MH2008PTC178070. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.15 M.
It upholds a compliant status. Employing 3 professional, Its leadership includes Rumy Ravi Kumar (Director), Ruby Ravi Kumar (Director). Past directors included Prabha Ravi Kumar. It holds ₹25.40 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 11A Sandeep Park Deonar, Mumbai, Maharashtra, 400088.
U24234MH2008PTC178070
178070
21 January 2008
₹1.00 M
₹0.15 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Ruby Biopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rumy Ravi Kumar | Director | 21 Jan 2008 | Current |
| Ruby Ravi Kumar | Director | 21 Jan 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Apr 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ruby Biopharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.26% increase. The company also saw a substantial improvement in profitability, with a 74.06% increase in profit. The company's net worth Soared by an impressive increase of 21.32%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Ruby Biopharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹254,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Dec 2024 | Axis Bank Limited | ₹14.00 Cr | Open |
| 21 Mar 2024 | Axis Bank Limited | ₹6.00 Cr | Open |
| 04 Mar 2024 | Axis Bank Limited | ₹5.40 Cr | Open |
Explore comprehensive loan charge details -
Ruby Biopharma has a workforce of 3 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ruby Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ruby Biopharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Axis Bank Limited amounted to Rs. 140.00 M with Charge ID 101010079 was registered on 03 Dec 2024. was documented.
The activity Ruby Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Ruby Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
A charge with Axis Bank Limited amounted to Rs. 60.00 M with Charge ID 100894143 was registered on 21 Mar 2024. was recorded as a recent event.
Progress on A charge with Axis Bank Limited amounted to Rs. 54.00 M with Charge ID 100886643 was registered on 04 Mar 2024. was documented.
Progress on Rumy Ravi Kumar was appointed as a Director was appointed as a Director on 21 Jan 2008 & has been associated with this company since 17 years 10 months . was documented.
The CIN of Ruby Biopharma Private Limited is U24234MH2008PTC178070.
Ruby Biopharma Private Limited is headquartered at 11A Sandeep Park Deonar, Mumbai, Maharashtra, 400088.
Ruby Biopharma Private Limited was incorporated on 21 January 2008.
The current directors of Ruby Biopharma Private Limited are
The primary industry of Ruby Biopharma Private Limited is Manufacturing.
Ruby Biopharma Private Limited is unlisted.
The authorized capital of Ruby Biopharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.15 M.
The compliance status of Ruby Biopharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX